Quantcast
Last updated on April 17, 2014 at 14:35 EDT

Latest Percutaneous coronary intervention Stories

2013-05-21 04:20:58

Volcano Highlights Two Products Intended to Expand the Role of Physiology in the Cath Lab SAN DIEGO, May 21, 2013 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC) a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced that it will demonstrate the Verrata(TM) Pressure Guide Wire and the iFR(®) (Instant wave-Free Ratio(TM)) modality throughout the week...

2013-05-21 04:20:47

PARIS, May 21, 2013 /PRNewswire/ -- The delayed healing of the coronary artery following physicians' use of drug eluting stents (DES), which increases patients' risks of developing thrombosis, is a top concern today of interventional cardiologists, according to the results of a survey announced at EuroPCR 2013 in Paris. In the online survey of 141 interventional cardiologists in Belgium, China, Denmark, Germany, Italy, Malaysia, The Netherlands, Singapore and the United Kingdom, participants...

2013-05-20 04:20:50

Results of Randomized JACK-EPC Trial Published in Minerva Cardioangiologica HONG KONG, May 20, 2013 /PRNewswire/ -- OrbusNeich today announced that the company's Genous Stent is associated with a significantly lower rate of binary restenosis compared to bare metal stents (BMS) in low-risk non-ST-segment elevation acute coronary syndrome (NSTE-ACS) patients at six months. Data from JACK-EPC, an investigator-initiated randomized study, were published in the June issue of Minerva...

2013-05-08 11:55:21

Research suggests new reporting protocol for 30-day mortality for percutaneous coronary intervention to better reflect quality, performance Only 42 percent of the deaths occurring within 30 days of percutaneous coronary interventions (PCI) were attributable to complications from the procedure, according to a Cleveland Clinic study published online in the Journal of the American College of Cardiology. The research suggests alternative outcome reporting mechanisms for 30-day mortality for...

2013-05-02 08:37:52

Expanding Reimbursement Coverage to Drive Adoption of High-End Devices in the Long Term, According to Millennium Research Group TORONTO, May 2, 2013 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, favorable demographics and growing economies are the main factors spurring rising revenues in the Latin American interventional cardiology (IC) device market. Economic growth is contributing to increased...

2013-05-02 08:37:14

-- Phase II, randomized, placebo-controlled study at Glenfield Hospital, University of Leicester (UK) will measure primary efficacy endpoint of change from baseline in left ventricular ejection fraction (LVEF) post-percutaneous coronary intervention (PCI) -- TORONTO, May 2, 2013 /PRNewswire/ -- CellAegis Devices, Inc., announced today the first clinical trial program in the European Union to evaluate the use of the Company's autoRIC(TM) Device for Chronic Remote Ischemic Conditioning...

2013-04-23 10:10:40

Researchers at the Stanford University School of Medicine have developed a method of predicting which patients with heart disease would benefit more from surgery and which would benefit more from angioplasty. Drawing on Medicare records of more than 100,000 patients with heart disease, the team demonstrated that the effectiveness of coronary bypass surgery varied widely based on each individual's characteristics. The data enabled them to predict which type of intervention – coronary...

2013-04-16 16:23:13

FARMINGTON, Mich., April 16, 2013 /PRNewswire/ -- Dr. Mark Rasak, MD is recognized by Continental Who's Who as a Pinnacle Professional in the field of Medicine as a result of his role as CEO of Cardiovascular Clinical Associates. Dr. Rasak has over 15 years of experience and specializes in managing all major aspects of the business; overseeing the daily operations; interventional cardiology; complex coronary angioplasty; as well as primary coronary intervention. In addition, he is an honored...

2013-04-16 12:27:17

Results from REMEDEE Confirm that the COMBO Stent Is Non-Inferior to DES HONG KONG, April 16, 2013 /PRNewswire/ -- OrbusNeich today announced that data from the REMEDEE (Randomized Evaluation of an abluMinal sirolimus coatED bio-Engineered stEnt) study published online in JACC: Cardiovascular Interventions demonstrated that the COMBO Dual Therapy Stent met the study's primary endpoint and was found to be effective in controlling neointimal proliferation. Specifically, the COMBO Stent...

2013-04-15 14:11:10

Minimally invasive procedure proves better than surgery when angioplasty fails in patients with severely blocked leg arteries Drug-eluting stents can keep clogged leg arteries open, preventing amputation of the leg, suggests research being presented at the Society of Interventional Radiology's 38th Annual Scientific Meeting in New Orleans. "Peripheral arterial disease (or PAD) is becoming increasingly prevalent due to our aging population and the obesity and diabetes epidemics," said...


Latest Percutaneous coronary intervention Reference Libraries

Coronary Angiography
2013-07-29 11:05:01

A coronary angiography, also known as a coronary catheterization, is a procedure that gives both visual and tactical access to coronary circulation and blood filled chambers of the heart for both diagnostic and interventional purposes. It is one of many diagnostic tests used in cardiology. More specifically, coronary catheterization recognizes occlusion, stenosis, thrombosis or aneurismal enlargement of the walls of the coronary arteries; heart chamber size; heart muscle contraction...

More Articles (1 articles) »